search
Back to results

NAVA Unloading - Effects on Distribution of Ventilation

Primary Purpose

Acute Respiratory Failure

Status
Unknown status
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Neurally adjusted ventilatory assist
PScli1
PScli2
Sponsored by
Karolinska University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Acute Respiratory Failure focused on measuring Neurally adjusted ventilatory assist

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients belonging to Neurosurgical ICU
  • Intubated for ≥48h
  • Weaning phase from Mechanical Ventilation

Exclusion Criteria:

  • bleeding disorders (PK INR>1,5 or APTT>50s or platelet count <50000/µL) or
  • unstable intracranial pressure (ICP>20 mmHg during the latest 8 hours) or
  • unstable circulation (requiring high vasopressor dose, for example Noradrenalin >0,2µg/kg/min) or
  • too severe lung disease (PFI ≤ 26,7 kPa or PEEP >10 cmH2O or FiO2>0,5 at study entry point) or
  • fever> 38,5°C or
  • tendency to hyperventilation (PaCO2 < 4,5 kPa at study entry point).

Sites / Locations

  • Dept. Anesthesiology, Surgical Services and Intensive Care Medicine,Karolinska Univeristy HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Arm Label

PScli1

NAVAcli

NAVA40%

NAVA60%

PScli2

Arm Description

Patients are ventilated in Pressure support (PS) according to the Clinical settings for 30min.

Patients are ventilated in Neurally Adjusted Ventilatory Assist (NAVA) and the assist is set in order to match to respiratory muscle unloading reached with PScli1. Patients are ventilated in NAVAcli for 30min.

Patients are ventilated in Neurally Adjusted Ventilatory Assist (NAVA) and the assist is set in order to target 40% muscle unloading based on the Neuro-Ventilatory Efficiency (NVE) measurement. Patients are ventilated in NAVA40% for 30min.

Patients are ventilated in Neurally Adjusted Ventilatory Assist (NAVA) and the assist is set in order to target 60% muscle unloading based on the Neuro-Ventilatory Efficiency (NVE) measurement. Patients are ventilated in NAVA60% for 30min.

Patients return to PS ventilation, according to the Clinical settings as in PScli1 for 30min.

Outcomes

Primary Outcome Measures

Center of Ventilation (CoV), expressed in percent (ventral to dorsal)
The distribution of ventilation is summarized by the CoV, a parameter obtained by the EIT monitor. Recordings are made at the end of each study step (total 5), lasting 30min.

Secondary Outcome Measures

Gas Exchange (PaO2 and PaCO2)
Comparison between study steps
Airway Pressure
Muscle unloading based on Neuro-Ventilatory Efficiency and Neuro-Mechanica Efficiency

Full Information

First Posted
March 14, 2016
Last Updated
April 14, 2016
Sponsor
Karolinska University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02711722
Brief Title
NAVA Unloading - Effects on Distribution of Ventilation
Official Title
Reduced Unloading in NAVA Improves Distribution of Ventilation in ICU Patients
Study Type
Interventional

2. Study Status

Record Verification Date
April 2016
Overall Recruitment Status
Unknown status
Study Start Date
June 2015 (undefined)
Primary Completion Date
September 2016 (Anticipated)
Study Completion Date
September 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska University Hospital

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Title: Reduced Unloading in NAVA Improves distribution of Ventilation in ICU patients. Objectives: To investigate if NAVA targeted to moderate respiratory muscular unloading results in redistribution of ventilation to the dorsal regions of the lungs To verify if the redistribution of ventilation translates to a better gas exchange and to a potentially lung protective ventilation strategy (lower airway pressures) To verify the possibility to set NAVA at different levels of unloading, based on Neuro-Ventilatory Efficiency. Study Design: Randomised Crossover of Pressure Support and NAVA at different levels of unloading. Population: Adult Intubated patients at the Neurosurgical ICU, ventilated for more than 48h, in weaning phase from mechanical ventilation. Study duration: 2,5h Number of subjects: 12
Detailed Description
Critically ill patients on mechanical ventilation are at risk for developing respiratory muscle atrophy. Partial Assist modes such Pressure Support (PS) and Neurally Adjusted Ventilatory Assist (NAVA) are developed to maintain patients´own effort in breathing. However there are no recommendations on how to set the optimal ventilator support in NAVA to avoid over- or underassistance. A previous Electrical Impedance Thomography (EIT) study has shown a redistribution of ventilation towards the dorsal regions of the lung in acute lung injury patients ventilated with NAVA, compared to PS. In the present study, the assist is targeted to different respiratory muscle unloading, predefined and based on the Neuro-Ventilatory Efficiency (NVE). The NVE will be measured at 10min intervals and NAVA level adjusted if needed, to keep constant the level of unloading in each study step. Protocol: Once enrolled, the patients are ventilated in PS (PScli1) as set by the clinician. They are then ventilated in NAVA at 3 different levels of muscle unloading in randomized order. At NAVAcli, the assist level matches to PScli1 in terms of muscle unloading. With NAVA40% and NAVA60%, the patients have 40% and 60% unloading, respectively. In the last study step the patients are back to PS (PScli2). Each patient is his/her own control and goes through the 5 ventilation periods, of 30min each. In the last 5 min of each study step, the CoV (obtained through the EIT data), blood gas samples (for oxygenation and ventilation) and ventilatory parameters are obtained and analyzed. The investigators hypothesize that It is possible to set NAVA at different levels of unloading, based on NVE. Moderate muscle unloading (corresponding to NAVA40%) keeps the diaphragm active and thereby leads to more dorsal distribution of ventilation compared to PScli and to higher unloading in NAVA. Secondarily and as a consequence of the redistribution of ventilation, we hypothesize that the gas exchange will remain unchanged or will improve and that the airway pressures will decrease for moderate unloading (NAVA40%).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Respiratory Failure
Keywords
Neurally adjusted ventilatory assist

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
12 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
PScli1
Arm Type
Active Comparator
Arm Description
Patients are ventilated in Pressure support (PS) according to the Clinical settings for 30min.
Arm Title
NAVAcli
Arm Type
Active Comparator
Arm Description
Patients are ventilated in Neurally Adjusted Ventilatory Assist (NAVA) and the assist is set in order to match to respiratory muscle unloading reached with PScli1. Patients are ventilated in NAVAcli for 30min.
Arm Title
NAVA40%
Arm Type
Active Comparator
Arm Description
Patients are ventilated in Neurally Adjusted Ventilatory Assist (NAVA) and the assist is set in order to target 40% muscle unloading based on the Neuro-Ventilatory Efficiency (NVE) measurement. Patients are ventilated in NAVA40% for 30min.
Arm Title
NAVA60%
Arm Type
Active Comparator
Arm Description
Patients are ventilated in Neurally Adjusted Ventilatory Assist (NAVA) and the assist is set in order to target 60% muscle unloading based on the Neuro-Ventilatory Efficiency (NVE) measurement. Patients are ventilated in NAVA60% for 30min.
Arm Title
PScli2
Arm Type
Active Comparator
Arm Description
Patients return to PS ventilation, according to the Clinical settings as in PScli1 for 30min.
Intervention Type
Device
Intervention Name(s)
Neurally adjusted ventilatory assist
Other Intervention Name(s)
NAVA
Intervention Description
Ventilation supported by NAVA Blood gas analysis Respiratory Parameters At the end of the study step Neuro-Ventilatory Efficiency and Neuro-Mechanical Efficiency are measured.
Intervention Type
Device
Intervention Name(s)
PScli1
Other Intervention Name(s)
Pressure support
Intervention Description
Pressure support set by clinicians prior to inclusion
Intervention Type
Device
Intervention Name(s)
PScli2
Other Intervention Name(s)
Pressure support
Intervention Description
Pressure support at the same level as prior to the study
Primary Outcome Measure Information:
Title
Center of Ventilation (CoV), expressed in percent (ventral to dorsal)
Description
The distribution of ventilation is summarized by the CoV, a parameter obtained by the EIT monitor. Recordings are made at the end of each study step (total 5), lasting 30min.
Time Frame
Total study time is 2,5 hours
Secondary Outcome Measure Information:
Title
Gas Exchange (PaO2 and PaCO2)
Description
Comparison between study steps
Time Frame
During the last 5min of each study step (each 30min), total 5 steps. Total study time 2,5 hours
Title
Airway Pressure
Time Frame
2,5 hours
Title
Muscle unloading based on Neuro-Ventilatory Efficiency and Neuro-Mechanica Efficiency
Time Frame
2,5 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients belonging to Neurosurgical ICU Intubated for ≥48h Weaning phase from Mechanical Ventilation Exclusion Criteria: bleeding disorders (PK INR>1,5 or APTT>50s or platelet count <50000/µL) or unstable intracranial pressure (ICP>20 mmHg during the latest 8 hours) or unstable circulation (requiring high vasopressor dose, for example Noradrenalin >0,2µg/kg/min) or too severe lung disease (PFI ≤ 26,7 kPa or PEEP >10 cmH2O or FiO2>0,5 at study entry point) or fever> 38,5°C or tendency to hyperventilation (PaCO2 < 4,5 kPa at study entry point).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Peter V Sackey, MD, PhD
Phone
+46851772066
Email
peter.sackey@karolinska.se
First Name & Middle Initial & Last Name or Official Title & Degree
Francesca Campoccia Jalde, MD
Phone
0046703947741
Email
francesca.campoccia-jalde@karolinska.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peter V Sackey, MD, PhD
Organizational Affiliation
Karolinska University Hospital
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Francesca Campoccia Jalde, MD
Organizational Affiliation
Karolinska University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dept. Anesthesiology, Surgical Services and Intensive Care Medicine,Karolinska Univeristy Hospital
City
Stockholm
ZIP/Postal Code
17176
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Francesca Campoccia Jalde, MD
Phone
0046703947741
Email
francesca.campoccia-jalde@karolinska.se
First Name & Middle Initial & Last Name & Degree
Peter V Sackey, MD, PhD
Phone
+46851772066
Email
peter.sackey@karolinska.se

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
18367735
Citation
Levine S, Nguyen T, Taylor N, Friscia ME, Budak MT, Rothenberg P, Zhu J, Sachdeva R, Sonnad S, Kaiser LR, Rubinstein NA, Powers SK, Shrager JB. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008 Mar 27;358(13):1327-35. doi: 10.1056/NEJMoa070447.
Results Reference
background
PubMed Identifier
10581089
Citation
Sinderby C, Navalesi P, Beck J, Skrobik Y, Comtois N, Friberg S, Gottfried SB, Lindstrom L. Neural control of mechanical ventilation in respiratory failure. Nat Med. 1999 Dec;5(12):1433-6. doi: 10.1038/71012. No abstract available.
Results Reference
background
PubMed Identifier
23553568
Citation
Blankman P, Hasan D, van Mourik MS, Gommers D. Ventilation distribution measured with EIT at varying levels of pressure support and Neurally Adjusted Ventilatory Assist in patients with ALI. Intensive Care Med. 2013 Jun;39(6):1057-62. doi: 10.1007/s00134-013-2898-8. Epub 2013 Apr 4.
Results Reference
background
PubMed Identifier
22849707
Citation
Liu L, Liu H, Yang Y, Huang Y, Liu S, Beck J, Slutsky AS, Sinderby C, Qiu H. Neuroventilatory efficiency and extubation readiness in critically ill patients. Crit Care. 2012 Jul 31;16(4):R143. doi: 10.1186/cc11451.
Results Reference
background
PubMed Identifier
22584798
Citation
Grasselli G, Beck J, Mirabella L, Pesenti A, Slutsky AS, Sinderby C. Assessment of patient-ventilator breath contribution during neurally adjusted ventilatory assist. Intensive Care Med. 2012 Jul;38(7):1224-32. doi: 10.1007/s00134-012-2588-y. Epub 2012 May 15.
Results Reference
background
PubMed Identifier
25882607
Citation
Liu L, Liu S, Xie J, Yang Y, Slutsky AS, Beck J, Sinderby C, Qiu H. Assessment of patient-ventilator breath contribution during neurally adjusted ventilatory assist in patients with acute respiratory failure. Crit Care. 2015 Feb 18;19(1):43. doi: 10.1186/s13054-015-0775-2.
Results Reference
background

Learn more about this trial

NAVA Unloading - Effects on Distribution of Ventilation

We'll reach out to this number within 24 hrs